Live feed08:30:00·1961dPRReleasevia QuantisnowRoyalty Pharma Acquires Royalty Interest in Seltorexant From Minerva NeurosciencesByQuantisnow·Wall Street's wire, on your screen.RPRX· Royalty Pharma plcNERV· Minerva Neurosciences IncHealth CareOriginal source
